1. Home
  2. MIST vs LSBK Comparison

MIST vs LSBK Comparison

Compare MIST & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • LSBK
  • Stock Information
  • Founded
  • MIST 2003
  • LSBK 1891
  • Country
  • MIST Canada
  • LSBK United States
  • Employees
  • MIST N/A
  • LSBK N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • LSBK Savings Institutions
  • Sector
  • MIST Health Care
  • LSBK Finance
  • Exchange
  • MIST Nasdaq
  • LSBK Nasdaq
  • Market Cap
  • MIST 81.5M
  • LSBK 76.9M
  • IPO Year
  • MIST N/A
  • LSBK 2006
  • Fundamental
  • Price
  • MIST $1.80
  • LSBK $13.71
  • Analyst Decision
  • MIST Strong Buy
  • LSBK
  • Analyst Count
  • MIST 3
  • LSBK 0
  • Target Price
  • MIST $13.00
  • LSBK N/A
  • AVG Volume (30 Days)
  • MIST 510.8K
  • LSBK 1.2K
  • Earning Date
  • MIST 11-12-2024
  • LSBK 10-23-2024
  • Dividend Yield
  • MIST N/A
  • LSBK 5.30%
  • EPS Growth
  • MIST N/A
  • LSBK N/A
  • EPS
  • MIST N/A
  • LSBK 0.75
  • Revenue
  • MIST N/A
  • LSBK $25,338,000.00
  • Revenue This Year
  • MIST N/A
  • LSBK N/A
  • Revenue Next Year
  • MIST N/A
  • LSBK N/A
  • P/E Ratio
  • MIST N/A
  • LSBK $18.20
  • Revenue Growth
  • MIST N/A
  • LSBK N/A
  • 52 Week Low
  • MIST $1.12
  • LSBK $10.12
  • 52 Week High
  • MIST $3.52
  • LSBK $14.21
  • Technical
  • Relative Strength Index (RSI)
  • MIST 68.42
  • LSBK 51.31
  • Support Level
  • MIST $1.75
  • LSBK $13.38
  • Resistance Level
  • MIST $2.09
  • LSBK $13.77
  • Average True Range (ATR)
  • MIST 0.15
  • LSBK 0.17
  • MACD
  • MIST 0.04
  • LSBK -0.02
  • Stochastic Oscillator
  • MIST 62.86
  • LSBK 47.14

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About LSBK Lake Shore Bancorp Inc.

Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.

Share on Social Networks: